Up to $900,000 for a maximum duration of three years. - Wednesday, March 11, 2026 (Application)
Breakthrough T1D, USThis funding opportunity aims to support translational research that advances the clinical application of vascularization and engraftment-focused strategies for islet replacement therapy in type (T1D).
